SALIVASPLIT
Live / Applied — New application — not yet assigned to an examiner (as of 05 Mar 2026)
What this means for you
Not registered yet, but its 05 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99686059
- Mark type
- Stylized text
- Filed
- 05 Mar 2026
- Attorney of record
- Yaling Zhou
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of HIV, Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis A (HAV), Helicobacter pylori infection (H. pylori), Dengue, and Syphilis; Chemical preparations for pharmaceutical or medical purposes, namely, for pregnancy testing preparations, tumor testing preparations, infectious disease testing preparations, cardiovascular disease testing preparations, drug testing preparations and immune disease testing preparations; Chemical preparations for the diagnosis of pregnancy; Chemical reagents for medical or veterinary purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for medical purposes; Pharmaceutical preparations for diagnosing infectious diseases, early stage pregnancy and tumors
- Class 010 — Medical apparatus: Blood testing apparatus; Cases fitted for medical instruments; Hematology analyzers for medical diagnostic uses; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus for detecting substance abuse drug testing and testing for infectious diseases, cardiovascular disease, cerebrovascular disease, and fertility testing, all using a colloidal gold readout and photoelectric sensors; Medical diagnostic instruments for the analysis of body fluids; Medical instruments for analysing and identifying bacteria
Owner
- Advin Biotech, Inc., San Diego, CA, US
Prosecution history
- 05 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 05 Mar 2026 — NEW APPLICATION ENTERED